Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Additional Articles by the Authors
Gary Branning, MBA
Kathryn Hayes, BA
Industry Trends
Healthcare Spending: Plenty of Blame to Go Around
Read More
Clinical
Benefits of Early Roflumilast Treatment After Hospital or Emergency Department Discharge for a COPD Exacerbation
Stakeholder Perspective
Continuing Challenges in COPD Management, Despite Its Prevalence and High Economic Burden
Read More
Drug Updates
,
FDA Approvals
,
Payers' Guide
Competition Heats Up in Rheumatoid Arthritis and Other Autoimmune Conditions
Read More
Business
,
Original Research
Anticipated Impact of Generic Imatinib Market Entry on the Costs of Tyrosine Kinase Inhibitors
Stakeholder Perspective
Generic Imatinib: Can It Provide Significant Cost Relief for Patients?
Read More
Pipeline
,
Payers' Guide
Once-Fatal Conditions Have Become Chronic: Early Trends in the FDA’s 2015 Approvals
Read More
1
2
Page 2 of 2
Results 11 - 15 of 15